Clinical trial
Personalized Hemodynamic Management Targeting Preoperative Baseline Cardiac Index in High-risk Patients Having Major Abdominal Surgery: the International Multicenter Randomized PELICAN Trial
NCT05648279 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Hemodynamic Management Targeting Preoperative Baseline Cardiac Index in High-risk Patients Having Major Abdominal Surgery: the International Multicenter Randomized PELICAN Trial
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 8, 2023
- Completion date
- January 15, 2026
- Enrollment
- 1,128 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
anesthesia, cardiac output, postoperative complications, surgery